America’s job market rebounded in November, adding 227,000 workers in a solid recovery from the previous month, when the effects of strikes and hurricanes had sharply diminished employers’ payrolls.
Last month’s hiring growth was …
He’s one of the most famous and widely admired corporate leaders in the world. But it’s the haters that companies like Mark Zuckerberg’s Meta worry about.In an era when online anger and social tensions are increasingly directed at th…
If you have a digital wallet or a banking app, you are one step away from cross-border payment capabilities at your fingertips. Learn all about cross-border payments, including challenges, potential, and innovations.
The debate over return to office (RTO) doesn’t seem to be going away. Many companies have opted for a hybrid model that allows employees to still work from home a couple days a week, while some major employers have introduced strict mandates tha…
Do you have employees who act more like “lone wolves” than team players? Individuals or teams who work in isolation from the larger organization can stifle innovation, limit knowledge sharing, and create resentment when others perceive the…
Professionals in midlife have faced a plethora of organizational challenges over the past few years, causing many to feel overwhelmed, burned out, or “in a rut.” While these challenges are not unique to midlife professionals, their experience often di…
Have you experienced that awkward moment when you meet a new colleague, notice a visible disability, and suddenly, all you know about everyday social interaction seems to go out the window? You are not sure what to say, what not to say, or where to lo…
A renewed focus on the 2013 data risk management regulatory standard poses new challenges and opportunities for European and US banks. Achieving compliance will take a structured, top-led approach.
A key task for 21st-century leaders is to develop their own capacity for change while also fostering resilience and adaptability in others across the organization. Here’s a blueprint for doing that.
An animal testing laboratory at Elon Musk’s Neuralink brain technology company was found to have “objectionable conditions or practices” by the Food and Drug Administration, which cited the company and urged it to address the problem…
